Tertiary Lymphoid Structures (TLSs) and Stromal Blood Vessels Have Significant and Heterogeneous Impact on Recurrence, Lymphovascular and Perineural Invasion amongst Breast Cancer Molecular Subtypes

Cells. 2023 Apr 17;12(8):1176. doi: 10.3390/cells12081176.

Abstract

Background: Tertiary lymphoid structures (TLSs) mediate local antitumor immunity, and interest in them significantly increased since cancer immunotherapy was implemented. We examined TLS- tumor stromal blood vessel interplay for each breast cancer (BC) molecular subtype related to recurrence, lymphovascular invasion (LVI), and perineural invasion (PnI).

Methods: TLSs were quantified on hematoxylin and eosin stain specimens followed by CD34/smooth muscle actin (SMA) double immunostaining for stromal blood vessel maturation assessment. Statistical analysis linked microscopy to recurrence, LVI, and PnI.

Results: TLS negative (TLS-) subgroups in each BC molecular subtype (except to Luminal A) have higher LVI, PnI, and recurrence. A significant rise in LVI and PnI were observed for the HER2+/TLS- subgroup (p < 0.001). The triple negative breast cancer (TNBC)/TLS- subgroup had the highest recurrence and invasion risk which was also significantly related to tumor grade. PnI but not LVI significantly influenced recurrence in the TNBC/TLS+ subgroup (p < 0.001). TLS-stromal blood vessel interrelation was different amongst BC molecular subtypes.

Conclusion: BC invasion and recurrence are strongly influenced by TLS presence and stromal blood vessels, especially for HER2 and TNBC BC molecular subtypes.

Keywords: TLS; breast cancer molecular subtypes; immature blood vessels; lymphovascular invasion; mature blood vessels; perineural invasion; recurrence; tertiary lymphoid structure.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast / pathology
  • Humans
  • Neoplasm Invasiveness
  • Tertiary Lymphoid Structures* / pathology
  • Triple Negative Breast Neoplasms*

Grants and funding

This research was funded by Victor Babes University of Medicine Research Department, Timisoara, Romania from internal funds of Research Department.